Statistics
Publications
27
Citations
2K
H-Index
25
Active since
1984
Donald B. Axworthy is an author at University of Washington specializing in cancer immunotherapy, medicine, and oncology.
Publications per year
1984–2019
27
27
A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Jody Schultz, Yukang Lin, James Sanderson et al. · PubMed · 2000 · 127 citations
In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Michael R. Lewis, Mu Wang, Donald B. Axworthy et al. · PubMed · 2003 · 110 citations
1–5 of 27